Skip to content
PeptideGeek

Growth hormone

CJC-1295 (No DAC), explained simply

A modified growth hormone-releasing hormone that boosts your body's natural GH pulses for better recovery, deeper sleep, and improved body composition.

Some human studiesInjection under the skin (like insulin shots)20 cited sourcesResearch compound — not FDA approved

Start here

What is CJC-1295 (No DAC)?

CJC-1295 without DAC, also called Modified GRF 1-29, is a short-acting, lab-made version of GHRH, the hormone that signals the pituitary (the master hormone gland at the base of the brain) gland to release growth hormone. Because it clears within hours, it boosts the body's natural growth hormone pulses rather than keeping levels raised continuously. It has early human trial evidence (Phase 1-2) but is a research compound, not FDA approved.

How it works in your body

Your brain naturally releases growth hormone in pulses throughout the day, especially during deep sleep 11 12. CJC-1295 without DAC is a modified version of the hormone (GHRH) that tells your pituitary (the master hormone gland at the base of the brain) gland to release GH. By mimicking this natural signal, it amplifies your body's own GH pulses rather than replacing them entirely 2. This keeps your hormonal feedback system working normally while boosting overall GH output.

The deeper mechanism, for the curious

CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF) is a lab-made copy of growth hormone-releasing hormone (GHRH), made of 29 amino acids. Four amino acid swaps (at positions 2, 8, 15, and 27) protect it from being chopped up by the enzyme DPP-IV, stretching its half-life (the time for half the drug to leave the body) from minutes to 30 minutes-2 hours 5 6. It binds GHRH receptors on somatotroph cells (growth-hormone-making cells) in the anterior pituitary (the front part of a gland at the base of the brain), switching on adenylyl cyclase (an enzyme) and raising cAMP (an internal messenger), which triggers GH (growth hormone) production and release 8. Unlike the DAC version, the no-DAC form produces short bursts of GH that mimic the body's natural pattern 7. When combined with a GHRP (a ghrelin (the hunger hormone) mimetic, a drug that copies the hunger hormone ghrelin), the two peptides work together through different receptors, producing GH release 3-5x greater than either alone. The short half-life means daily dosing, but it gives more precise control over when GH is released.

Evidence check

Some human studies

It has been tested in people, but only in small or early-stage studies. Promising, but not yet proven the way an approved medicine is.

Every numbered marker on this page links to one of the 20 sources at the bottom.

88/100

Growth hormone (GH) boost

Effectively stimulates natural GH release in pulsatile pattern, especially when combined with GHRPs

92/100

Sleep Quality

One of the most reliably noticed benefits, with deeper sleep and more refreshed mornings

85/100

Recovery Support

Enhances workout recovery and tissue repair through elevated GH and IGF-1 levels

What the research points to

  • Stimulates natural growth hormone release in healthy pulses
  • Supports muscle growth and a better body makeup (more muscle, less fat)
  • Enhances deep, restorative sleep
  • Speeds recovery from workouts and injuries
  • Promotes fat burning and lean body mass
  • Works together with GHRP peptides (peptides that also trigger growth hormone) like Ipamorelin

The most-asked question

How much CJC-1295 (No DAC) do I take?

The research-reported range is 100 mcg, once daily. Studies used different doses for different situations — find yours:

  1. First-time users, Sleep and recovery

    100 mcg

    • How often
      Once daily, 30 minutes before bed
    • For how long
      2-4 weeks
    • How
      Injection under the skin

    A common starting dose used in research practice. Because the no-DAC form is short-acting (about 30 minute half-life (how long it stays active in your body)), it is injected on an empty stomach for the best growth-hormone pulse. 1415

  2. Body composition, Recovery

    100 mcg per dose

    • How often
      1-2 times daily
    • For how long
      8-12 weeks
    • How
      Injection under the skin

    The typical maintenance dose used in practice, often given before bed and/or after fasted exercise. Frequently paired with a GH-releasing peptide.

  3. Experienced users, Maximizing GH pulses

    100 mcg per dose

    • How often
      2-3 times daily
    • For how long
      8-12 weeks
    • How
      Injection under the skin

    A higher-frequency plan used by experienced users to mimic natural GH pulses across the day, each dose taken fasted.

Adjusting your dose

You're at the right dose if…

  • Deeper, more restful sleep
  • Improved recovery between workouts
  • Gradual improvements in body composition
  • Increased energy and vitality

Consider going up if…

  • Tolerating current dose well with no side effects
  • Not experiencing noticeable sleep or recovery improvements
  • Body composition changes have plateaued
  • Want to add a second daily dose

Go down if…

  • Experiencing persistent water retention
  • Tingling or numbness is uncomfortable
  • Feeling overly fatigued
  • Injection site reactions are bothersome

The ceiling: 300 mcg per injection, up to 3 times daily

Reconstitution, in plain words

How do I mix CJC-1295 (No DAC)?

Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for CJC-1295 (No DAC):

What you need

  • Bacteriostatic water (BAC water)
  • Insulin syringe (29-31 gauge)
  • Alcohol swabs
  • Sterile vial of CJC-1295 powder

A worked example

2mg vial + 2mL BAC water = 1mg/mL (1000mcg/mL). This means each 0.1mL contains 100mcg.

Working out your dose

For 100mcg dose at 1mg/mL concentration: draw 0.1mL (10 units on insulin syringe)

Or let the calculator do it

Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with CJC-1295 (No DAC)'s recorded schedule.

CJC-1295 (No DAC)Once daily, 30 minutes before bed

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Injection sites & technique

Where do I inject CJC-1295 (No DAC)?

The best spots

  • Abdomen (2 inches from navel)
  • Lower belly fat roll
  • Upper thigh (front or outer)

How to do it, step by step

  • Clean injection site with alcohol swab and let dry
  • Pinch a fold of skin between thumb and forefinger
  • Insert needle at 45-90 degree angle into pinched skin
  • Inject solution slowly
  • Remove needle and apply light pressure (do not rub)

Injection into the fatty layer under the skin

Timing

When do I take CJC-1295 (No DAC)?

Best time of day

Before bed on empty stomach (most popular), or morning fasted and pre-workout

With or without food?

Take on an empty stomach - wait at least 2 hours after eating and 30-60 minutes before eating

The honest list

What side effects could CJC-1295 (No DAC) cause?

Common — usually mild

These show up most often. They usually fade as your body adjusts.

  • Injection site reactions

    Temporary redness, swelling, or mild pain at injection site

    What to do Rotate injection sites, ensure proper technique, apply ice if needed

  • Flushing or warmth

    Brief feeling of warmth or facial flushing shortly after injection

    What to do Usually resolves within 15-30 minutes, no treatment needed

  • Water retention

    Mild fluid retention, especially in first few weeks

    What to do Usually temporary, reduce sodium intake if bothersome

  • Increased appetite

    GH stimulation can increase hunger

    What to do Plan meals accordingly, can be beneficial for muscle-building goals

Less common

Worth knowing about, but most people never see these.

  • Tingling or numbness

    Paresthesias in hands or feet, similar to mild carpal tunnel

    What to do Reduce dose if persistent, usually resolves with continued use

  • Headache

    Occasional headaches, especially when starting

    What to do Stay hydrated, usually resolves within first week

Serious — stop and get medical help

Rare, but if any of these happen, stop and contact a medical professional.

  • Allergic reaction

    Rare hypersensitivity including hives, swelling, or difficulty breathing

    What to do Discontinue immediately and seek medical attention

Week by week

What should I expect from CJC-1295 (No DAC), and when?

  1. Week 1-2

    You might notice
    • Improved sleep quality and deeper rest
    • More vivid dreams
    • Subtle increase in energy levels
    • Possible mild water retention
    • Injection site may be slightly red initially
    What's normal
    • Sleep improvements are often the first noticeable effect
    • Mild side effects like flushing are common and temporary
    • Don't expect dramatic physical changes yet
    What's next
    • Continue at starting dose if tolerating well
    • Track sleep quality and energy in a journal
    • Consider adding a GHRP if not already stacking
  2. Week 3-4

    You might notice
    • Faster recovery between workouts
    • Improved skin appearance and hydration
    • Gradual fat loss beginning
    • Better workout performance
    • Sustained energy throughout the day
    What's normal
    • Recovery benefits become more apparent
    • Physical changes are still subtle
    • Side effects should be minimal by now
    What's next
    • Consider increasing dose if effects are mild
    • Ensure proper nutrition to support muscle growth
    • May add second daily dose for enhanced results
  3. Week 5-8

    You might notice
    • Noticeable improvements in body composition
    • Increased lean muscle mass
    • Continued fat reduction
    • Better skin elasticity and appearance
    • Improved sense of well-being
    What's normal
    What's next
    • Continue protocol through week 8-12
    • Consider lab work to check IGF-1 (a growth signal your liver releases in response to growth hormone) levels
    • Maintain consistent injection schedule
  4. Week 9-12+

    You might notice
    • Sustained improvements in muscle and fat ratio
    • Continued enhanced recovery
    • Stable sleep and energy benefits
    • Overall improved physical performance
    • Anti-aging effects more noticeable
    What's normal
    • Benefits plateau at optimal levels
    • Consistent results with continued use
    • Some users cycle off for 4-8 weeks before restarting
    What's next
    • Decide on cycling strategy with healthcare provider
    • May take 4-8 week break before next cycle
    • Maintain lifestyle factors to preserve gains

How to tell it's actually working

Sleep and Recovery

  • Falling asleep faster and sleeping more deeply
  • Waking up feeling more refreshed
  • More vivid or memorable dreams
  • Faster recovery between workouts
  • Less muscle soreness after training

Muscle and fat balance

  • Gradual reduction in body fat
  • Increased lean muscle mass
  • Improved muscle definition
  • Clothes fitting differently (looser around waist, tighter around shoulders)
  • Better muscle pumps during workouts

Overall Vitality

  • Improved energy throughout the day
  • Better skin quality and elasticity
  • Stronger nails and healthier hair
  • Improved mood and sense of well-being
  • Enhanced exercise performance

Not seeing anything? The usual reasons

Is it right for you?

Who should avoid CJC-1295 (No DAC)?

Do not use it if…

  • You have active cancer or a history of cancer (growth hormone may promote tumor growth)
  • You are pregnant or breastfeeding
  • You have a pituitary (the master hormone gland at the base of the brain) tumor or untreated pituitary disorder
  • You have had an allergic reaction to GHRH (growth hormone-releasing hormone) or drugs like it
  • You have uncontrolled diabetes or diabetic retinopathy (diabetes damage to the eye)
  • You have active Cushing's disease or syndrome (a condition of too much cortisol (the stress hormone))

Be extra careful if…

  • You have diabetes (may affect blood sugar regulation)
  • You are taking insulin or diabetes medications
  • You have carpal tunnel syndrome (GH may worsen symptoms)
  • You have a history of joint pain or arthritis
  • You are over 65 years old (start with lower doses)
  • You have impaired kidney or liver function

When to stop

  • Signs of allergic reaction (hives, swelling, difficulty breathing)
  • Persistent severe headaches that don't improve
  • Significant joint pain or carpal tunnel symptoms
  • Development of diabetes symptoms (excessive thirst, frequent urination)
  • Any concerning changes in moles or skin growths
  • Planned surgery (stop 1-2 weeks before)

Always consult with a healthcare provider before starting or stopping peptide therapy. This information is for educational purposes and does not replace medical advice.

What it mixes badly (and well) with

Medications

  • Avoid
    Insulin

    May affect blood sugar control, monitor closely

  • Avoid
    Diabetes medications

    GH can raise blood sugar - doses may need adjusting

  • Avoid
    Glucocorticoids (Prednisone)

    May make CJC-1295 work less well

  • Check first
    Thyroid medications

    Generally safe but monitor thyroid levels

Other peptides

  • OK together
    Ipamorelin

    Works very well together - combining a GHRH (the brain signal that releases growth hormone) with a GHRP (a drug that also triggers it) boosts GH release 3-5x more than either alone

  • Check first
    GHRP-6

    Works well together but may increase hunger more than the Ipamorelin combination

  • OK together
    GHRP-2

    Effective combination with a moderate increase in hunger

  • OK together
    BPC-157

    Can be used together for enhanced healing and recovery

  • Avoid
    CJC-1295 with DAC

    Does the same job - do not combine, as both are GHRH analogs (lab-made copies of the GHRH signal)

Supplements

  • OK together
    Arginine

    May boost GH release, safe to combine

  • OK together
    GABA

    May support GH release and sleep quality

  • OK together
    Melatonin

    Safe for bedtime dosing, may enhance sleep benefits

  • Avoid
    High-dose carbohydrates

    Eating carbs/sugar before injection blunts the GH response - avoid

Who it tends to suit

Natural Growth Hormone Optimization

Perfect for those wanting to boost their body's own GH production rather than using synthetic growth hormone. Mimics the natural pulsatile release pattern your pituitary (the master hormone gland at the base of the brain) uses 2.

The safety picture overall

CJC-1295 without DAC itself has not been evaluated in controlled human clinical trials; expectations about its safety are extrapolated from studies of related GHRH analogs (modified versions of a natural molecule). The most common side effects are mild and include injection site reactions and temporary flushing 19. Because it stimulates natural GH release rather than providing exogenous (supplied from outside the body) GH, it maintains the body's feedback mechanisms 2.

Human studies at doses up to 90mcg/kg showed no serious adverse events 1. However, most research has been relatively short-term. Long-term safety data in humans is limited compared to FDA-approved medications.

Keeping it good

How do I store CJC-1295 (No DAC)?

Before mixing (powder)

Store lyophilized (freeze-dried) powder in freezer at -20C for long-term storage (years) or refrigerator at 2-8C for up to 12 months. Keep in original vial away from light and moisture.

After mixing (liquid)

Refrigerate immediately at 36-46F (2-8C). Never freeze reconstituted peptide. Keep vial upright and away from light. Use within 21-28 days.

Signs it has gone bad

  • Cloudy or hazy solution (should be crystal clear)
  • Visible particles or floating matter
  • Solution that has been left at room temperature for extended periods
  • Any discoloration from the original clear appearance

Not our opinion — the published record

What the studies actually found about CJC-1295 (No DAC)

1994

Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences

Natural human GRF (another name for GHRH) is switched off in three ways: DPP-IV cutting between residues 2 and 3, chemical rearrangement at Asn8, and oxidation (damage by oxygen) at Met27. Analogues (lab-made copies) built with swaps at position 2 (to block DPP-IV), position 8 (to reduce rearrangement), position 15 (Ala15, which improves receptor binding) and position 27 (Leu27, to prevent oxidation) completely resisted DPP-IV cutting over 24 hours and were 11- to 13-fold more potent than natural GRF when injected into pigs.

Campbell RM, Stricker P, Miller R, Bongers J, Liu W, Lambros T, Ahmad M, Felix AM, Heimer EP

2005

Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog

Injecting the unconjugated (no albumin tag) four-swap hGRF(1-29) versions under the skin in rats produced a short burst of growth hormone in blood plasma. The albumin-binding version, CJC-1295, was still detectable in plasma beyond 72 hours.

Jette L, Leger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP

1995

Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level

In healthy adults, growth hormone released over 120 minutes measured 484 ug/L per min after GHRH alone and 1435 after GHRP-6 alone, but 3772 when the two were given together. The combined response was significantly greater than the two given separately added together.

Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF

If this isn't the right fit

What people use instead of CJC-1295 (No DAC)

Longer-lasting growth hormone (GH) boost

  • CJC-1295 with DAC
  • Tesamorelin

Simpler dosing protocol

  • Sermorelin
  • CJC-1295 with DAC

Direct growth hormone (GH) replacement

  • HGH (Somatropin)
  • HGH Fragment 176-191

GHRP-only approach (drugs that trigger GH release without the GHRH signal)

  • Ipamorelin
  • GHRP-6
  • GHRP-2

Your questions

CJC-1295 (No DAC) FAQ

What's the difference between CJC-1295 with DAC and without DAC?

The DAC (Drug Affinity Complex) version attaches to albumin in your blood, extending its half-life (how long it stays active in your body) to 6-8 days for weekly dosing 1. The no-DAC version has a short half-life of 30 minutes to 2 hours, requiring daily dosing but producing more natural GH pulses. Most users prefer no-DAC for its more physiological release pattern and ability to fine-tune dosing.

Why should I combine CJC-1295 with Ipamorelin?

CJC-1295 and Ipamorelin work through different docking points on cells (receptors) 10, but both stimulate GH release. Together they create a synergistic effect that releases 3-5 times more GH than either peptide alone. Think of CJC-1295 as pressing the gas pedal while Ipamorelin releases the parking brake - together they're far more effective.

Why do I need to take it on an empty stomach?

Food, especially carbohydrates, triggers insulin release. Insulin significantly blunts the GH response to CJC-1295 15. Taking it fasted (2+ hours after eating) ensures maximum GH release. This is why bedtime dosing is popular - most people haven't eaten for several hours before sleep.

How long until I see results?

Sleep improvements are often noticed within the first week. Enhanced recovery and energy typically appear by weeks 2-3. Visible body composition changes (less fat, more muscle) usually take 6-8 weeks of consistent use. Full benefits are typically seen by week 12.

Is CJC-1295 without DAC the same as Mod GRF 1-29?
Can I use CJC-1295 without DAC for anti-aging?
Do I need to take CJC-1295 without DAC in on-and-off cycles?

Many users follow 8-12 week cycles with 4-8 week breaks, though some use it continuously. Cycling may help keep your cells responsive (receptor sensitivity) and prevent tolerance. There's no definitive research on the best cycling plan, so consult a healthcare provider familiar with peptides.

What time of day is best for injection?

Most users prefer bedtime dosing because GH is naturally released during deep sleep, 1112 and taking it fasted is easier at night. Some users add a morning fasted dose for additional benefits. Pre-workout dosing is another option as GH supports exercise performance and recovery.

20 sources

References

Every numbered marker on this page points to one of these. Same sources, same numbering as the CJC-1295 (No DAC) research profile on Peptide Initiative.

  1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsTeichman et al. · 2006
  2. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295Ionescu M, Frohman LA · 2006
  3. Once-daily administration of CJC-1295 normalizes growth in the GHRH knockout mouseAlba M, Fintini D, Sagazio A et al. · 2006
  4. Activation of the GH/IGF-1 axis by CJC-1295 results in serum protein profile changes in normal adult subjectsSackmann-Sala L, Ding J, Frohman LA et al. · 2009
  5. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasmaFrohman LA, Downs TR, Heimer EP, Felix AM · 1989
  6. Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequencesCampbell RM, Stricker P, Miller R, Bongers J, Liu W, Lambros T, Ahmad M, Felix AM, Heimer EP · 1994
  7. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analogJette L, Leger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP · 2005
  8. Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormoneMayo KE · 1992
  9. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic levelPopovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF · 1995
  10. Ipamorelin, the first selective growth hormone secretagogueRaun K, Hansen BS, Johansen NL, Thogersen H, Madsen K, Ankersen M, Andersen PH · 1998
  11. Growth hormone secretion during sleepTakahashi Y, Kipnis DM, Daughaday WH · 1968
  12. Interrelationships between growth hormone and sleepVan Cauter E, Copinschi G · 2000
  13. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controlsSteiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F · 1992
  14. Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in manGhigo E, Miola C, Aimaretti G, Valente F, Procopio M, Arvat E, Yin-Zhang W, Camanni F · 1992
  15. Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjectsLanzi R, Manzoni MF, Andreotti AC, Malighetti ME, Bianchi E, Sereni LP, Caumo A, Luzi L, Pontiroli AE · 1997
  16. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy menIranmanesh A, Lizarralde G, Veldhuis JD · 1991
  17. Effects of human growth hormone in men over 60 years oldRudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE · 1990
  18. Metabolic effects of a growth hormone-releasing factor in patients with HIVFalutz J, Allas S, Blot K, Potvin D, Kotler D, Somero M, Berger D, Brown S, Richmond G, Fessel J, Turner R, Grinspoon S · 2007
  19. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiencyPrakash A, Goa KL · 1999
  20. Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of lifeMesa J, Gomez JM, Hernandez C, Pico A, Ulied A · 2003

Want the deep science?

Read the full CJC-1295 (No DAC) research profile

Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.

Open the research profile

More growth hormone guides

This guide is education, not medical advice. CJC-1295 (No DAC) is a research compound that is not FDA-approved for human use. Talk to a clinician before taking anything.